Comparing Baseline and Day-1 Diffusion MRI Using Multimodal Deep Embeddings for Stroke Outcome Prediction

arXiv:2512.02088 · eess.IV, cs.AI, cs.CV, cs.LG · Submitted 2025-12-01 · Read on arXiv

eess.IV, cs.AI, cs.CV, cs.LG

Submitted: 2025-12-01

Updated: 2025-12-01

Comments: 5 pages, 5 figures, 2 tables

Journal ref: 2026 IEEE 23rd International Symposium on Biomedical Imaging (ISBI), 2026, pp. 1-5

DOI: 10.1109/ISBI61618.2026.11515670

License: http://creativecommons.org/licenses/by-nc-sa/4.0/

The gist: This study compares baseline (J0) and 24-hour (J1) diffusion magnetic resonance imaging (MRI) for predicting three-month functional outcomes after acute ischemic stroke (AIS).

Terminology

Abstract

This study compares baseline (J0) and 24-hour (J1) diffusion magnetic resonance imaging (MRI) for predicting three-month functional outcomes after acute ischemic stroke (AIS). Seventy-four AIS patients with paired apparent diffusion coefficient (ADC) scans and clinical data were analyzed. Three-dimensional ResNet-50 embeddings were fused with structured clinical variables, reduced via principal component analysis (<=12 components), and classified using linear support vector machines with eight-fold stratified group cross-validation. J1 multimodal models achieved the highest predictive performance (AUC = 0.923 +/- 0.085), outperforming J0-based configurations (AUC <= 0.86). Incorporating lesion-volume features further improved model stability and interpretability. These findings demonstrate that early post-treatment diffusion MRI provides superior prognostic value to pre-treatment imaging and that combining MRI, clinical, and lesion-volume features produces a robust and interpretable framework for predicting three-month functional outcomes in AIS patients.

Related papers